12 results about "Adenophora stricta" patented technology

The invention discloses a traditional Chinese medicine tea drink for preventing and treating oral mucosa diseases and a preparation method of the traditional Chinese medicine tea drink. The traditional Chinese medicine tea drink is prepared from 10-15 parts of radix astragali, 8-12 parts of radix codonopsis, 6-10 parts of radix salviae miltiorrhizae, 5-9 parts of radix angelicae sinensis, 3-6 parts of fructus psoraleae, 6-9 parts of rhizoma polygonati, 6-9 parts of radix adenophorae, 6-10 parts of rhizoma atractylodis macrocephalae, 5-9 parts of radix ophiopogonis, 3-5 parts of radix glycyrrhizae, 4-6 parts of pericarpium citri reticulatae and 5-8 parts of herba taraxaci. Aiming at the core pathogenesis of low immunity, long-term deficiency, long-term deficiency and kidney-yang insufficiency of patients suffering from oral mucosa diseases, qi tonifying, blood activating and kidney-qi strengthening are taken as a core treatment method, the formula is scientific and reasonable, all the medicinal materials act synergistically, the overall immune function of the body is adjusted, T lymphocyte subpopulation imbalance and cell factor network disorder are improved, and the curative effect is good. The oral mucosa microcirculation is improved, local inflammation is relieved, the immunity of a patient is improved fundamentally, the recurrence rate of oral mucosa diseases is reduced, and the problems that an existing tea drink is not high in pertinence and limited in curative effect are solved. The tea drink is appropriate in taste, good in compliance, high in safety and suitable for people with various oral mucosa diseases and low immunity.

This invention belongs to the field of traditional Chinese medicine technology, specifically relating to the application of a formula for nourishing vital energy and strengthening the body in reducing the toxicity of adjuvant chemotherapy after radical resection of non-small cell lung cancer. This invention discloses a formula for nourishing vital energy and strengthening the body, characterized in that it is composed of the following components by weight: 15-30 parts raw Astragalus membranaceus, 9-21 parts prepared Rehmannia glutinosa, 15-30 parts stir-fried Dioscorea opposita, 9-15 parts Atractylodes macrocephala, 9-15 parts Poria cocos, 15-30 parts raw Coix lacryma-jobi, 9-15 parts Ophiopogon japonicus, 9-15 parts Asparagus cochinchinensis, 15-30 parts Adenophora stricta, 9-15 parts Ligustrum lucidum, 9-15 parts Eclipta prostrata, 9-15 parts stir-fried germinated barley, 9-15 parts stir-fried malt, and 3-6 parts prepared Glycyrrhiza uralensis. This invention can restore vital energy, reverse postoperative weakness, build a foundation for chemotherapy tolerance to reduce toxic side effects, improve chemotherapy tolerance, reduce the risk of interruption to ensure efficacy, improve quality of life during chemotherapy, and help prolong postoperative survival.

This application provides a traditional Chinese medicine tea for the prevention or treatment of upper respiratory tract infections, its preparation method, and its application. The tea is made from the following raw materials in parts by weight: 2-4 parts of Scrophularia ningpoensis, 2-4 parts of Ophiopogon japonicus, 1-3 parts of Adenophora stricta, 2-4 parts of Adenophora stricta, 2-4 parts of Scutellaria baicalensis, 0.5-1.5 parts of Platycodon grandiflorus, 0.5-1.5 parts of Belamcanda chinensis, 0.5-1.5 parts of Lonicera japonica, 0.5-1.5 parts of Oroxylum indicum, and 1-3 parts of Glycyrrhiza uralensis. The raw materials in this application are formulated and the components of the traditional Chinese medicine are quantified and proportioned through precise cutting parameters, and the preservation of the precisely cut herbs is controlled. This allows the tea to: nourish Yin and moisten dryness, replenish Qi and generate fluids, clear heat from the upper burner, treat dry and itchy throat, sore throat, dry cough, and prevent upper respiratory tract infections.

This invention discloses a traditional Chinese medicine composition for treating tumors and its preparation method, belonging to the field of traditional Chinese medicine technology. The composition comprises *Uncaria rhynchophylla*, *Prunella vulgaris*, *Astragalus membranaceus*, *Adenophora stricta*, *Ophiopogon japonicus*, *Fritillaria thunbergii*, *Curcuma zedoaria*, *Panax notoginseng*, *Atractylodes macrocephala* (fried), *Ligustrum lucidum*, *Eclipta prostrata*, and *Glycyrrhiza uralensis* (processed). The formula focuses on clearing heat and detoxifying, resolving phlegm and dissipating nodules, strengthening the body's resistance, and promoting blood circulation and removing blood stasis. It combines tonification and purgation, addressing both the root cause and symptoms, precisely targeting the core pathogenesis of tumors: deficiency of vital energy, phlegm accumulation, blood stasis, and toxin accumulation. It can inhibit tumor cell proliferation, dissipate masses, enhance the body's immunity, reduce adverse reactions to radiotherapy and chemotherapy, improve clinical symptoms, stabilize tumors, and delay tumor progression and recurrence / metastasis, showing promising clinical application prospects.

This invention relates to the field of traditional Chinese medicine (TCM) technology, and particularly to a TCM composition, preparation, preparation method, and application for use in the peri-discharge period of acute exacerbations of COPD. The TCM composition comprises the following raw materials: 10-20 parts of *Codonopsis pilosula*, 10-25 parts of *Adenophora stricta*, 15-30 parts of *Clam shell*, 8-15 parts of *Fritillaria thunbergii*, 8-12 parts of *Platycodon grandiflorus*, 8-15 parts of *Paeonia lactiflora*, 8-12 parts of *Aster tataricus*, 8-12 parts of *Lepidium apetalum*, and 8-12 parts of *Pheretima aspergillum*. The TCM preparation derived therefrom can be in the following dosage forms: decoction, paste, tablets, capsules, granules, pills, powders, drop pills, mixtures, or oral liquids. It can be used to prepare drugs that relieve cough, sputum, and shortness of breath, and is suitable for the peri-discharge period of acute exacerbations of COPD.

This invention provides a traditional Chinese medicine composition for treating allergic rhinitis, its preparation method, and its application. The effective components of the traditional Chinese medicine composition are made from the following raw materials in parts by weight: Astragalus membranaceus 3-50, Atractylodes macrocephala 3-30, Saposhnikovia divaricata 3-30, Magnolia biondii 3-30, Xanthium sibiricum (fried) 3-30, Ganoderma lucidum 3-50, Platycodon grandiflorus 3-30, calcined dragon bone 5-50, calcined oyster shell 5-50, Terminalia chebula 3-30, Adenophora stricta 3-30, Cordyceps sinensis mycelium powder 3-30, and Dictamnus dasycarpus 3-30. The raw materials of this traditional Chinese medicine composition are common, the preparation method is simple and easy to operate, and it has wide application value. Oral administration of the drug significantly improves nasal sensitivity symptoms in a mouse model of allergic rhinitis, reduces the levels of IgE and histamine in serum and nasal lavage fluid, reduces the level of inflammatory factors in serum, and inhibits the number of inflammatory cells and mast cells in the nasal mucosa, thus effectively treating allergic rhinitis.

This invention discloses a lung-nourishing Solomon's Seal Ointment, its preparation method, and its application, relating to the field of traditional Chinese medicine technology. The herbal composition comprises three herbs: Herb A, Herb B, and Herb C. Herb A includes Solomon's Seal, Lycium barbarum, Chrysanthemum indicum, Mulberry fruit, White peony root, Rehmannia glutinosa, Raw Chinese yam, Ziziphus jujuba peel, Moutan bark, and Poria cocos. Herb B includes Achyranthes bidentata, Polygonatum sibiricum (processed with wine), Ophiopogon japonicus, Adenophora stricta, Tangerine peel, Prepared licorice root, Astragalus membranaceus, and Anemarrhena asphodeloides. The lung-nourishing Solomon's Seal Ointment is prepared by combining Herbs A and B in the herbal composition, decocting them in water, filtering the filtrate, concentrating the liquid, adding Herb C to dissolve, and then simmering over low heat to form an ointment. This technical solution is applied to the treatment of chronic obstructive pulmonary disease (COPD), forming a multi-target, holistic conditioning system. It provides crucial synergistic value to Western medicine's strategy of simply controlling symptoms in improving chronic COPD symptoms and enhancing quality of life, thereby improving the quality of life for COPD patients.

This invention provides a lung-clearing and cough-relieving herbal remedy, which, based on the total weight percentage of the dried plant materials used to prepare the remedy, comprises the following main components: 8-10% *Corydalis yanhusuo*, 8-10% *Gnaphalium affine*, 8-10% *Citrus reticulata* peel, 7-10% *Houttuynia cordata*, 7-10% *Trichosanthes kirilowii*, 7-9% *Houttuynia cordata*, 7-9% *Polygonum cuspidatum*, 7-9% *Sarcandra glabra*, 6-8% *Adenophora stricta*, 6-8% *Fritillaria cirrhosa*, and 5-7% *Perilla frutescens*. This invention utilizes 11 medicinal herbs... Among the list of items that are both food and medicine, this product is precisely formulated according to the theories of "four qi and five flavors" and meridian tropism. It is rich in natural active ingredients such as fritillary alkaloids, fritillary alkaloid A and B, hesperidin, and houttuynia cordata. It has both dietary and medicinal properties, and is extremely safe. In the first stage, it targets and detoxifies, clears blood vessels and eliminates the root cause of the disease. In the second stage, it reduces inflammation and kills bacteria, repairs damaged alveoli and promotes regeneration. This progressive treatment can not only dissipate pulmonary ground-glass nodules and solid nodules, but also inhibit density transformation and prevent recurrence.

This application discloses a method for preparing a traditional Chinese medicine rice wine with stomach-nourishing and fluid-generating effects, comprising the following steps: Preparation of base materials and medicinal liquid: Glutinous rice is soaked, steamed, and then air-cooled to 30°C. Separately, coarse powders of Dendrobium officinale, Ophiopogon japonicus, Adenophora stricta, and Polygonatum odoratum are extracted by percolation with rice wine base liquor and sterilized to obtain herbal extract; Saccharification and fermentation: Cooled glutinous rice, wheat koji, Jianhu water, wine yeast, and herbal extract are mixed and saccharified and fermented at 28-32°C for 72 hours; Post-fermentation and pressing: Post-fermentation is carried out at 15-20°C for 45 days until the alcohol content reaches 12% vol, and the initial brewed liquid is pressed; Refining and aging: Sucrose and citric acid are added, and the mixture is refrigerated at 4°C for 72 hours, then microfiltered at 0.45 μm and sterilized by decoction, finally placed in earthenware jars and aged at 10-18°C for 60-90 days. Therefore, this method follows the logic of traditional Chinese medicine compatibility, using the warming properties of rice wine to balance the cold properties of herbs, so that the product has the effects of benefiting the stomach and promoting body fluid production, protecting the liver and kidneys, and anti-oxidation, thus achieving a balance between emotional value and health benefits.

This invention relates to the field of traditional Chinese medicine conditioning technology, specifically providing a traditional Chinese medicine composition for sub-health conditioning and its preparation method. The components include: Asparagus cochinchinensis, Ophiopogon japonicus, Polygonatum odoratum, Dendrobium nobile, Adenophora stricta, Atractylodes macrocephala, Poria cocos, Citrus reticulata peel, and Amomum villosum. This traditional Chinese medicine composition for sub-health conditioning possesses a unique system of nourishing yin and clearing heat, strengthening the spleen and removing dampness, thus simultaneously nourishing yin and clearing damp-heat.

The present invention relates to the technical field of Mongolian medicine, and discloses a Mongolian medicine named Renqing Wugete Busan for treating Heretic lung disease. This Mongolian medicine is composed of twenty-six medicinal materials including Gentiana algida Pall., Aquilaria sinensis (Lour.) Gilg, Choerospatha eriostachya (Wall.) Miq., Santalum album Linn., Myristica fragrans Houtt., Gypsum Fibrosum, Adenophora stricta Miq., Aucklandia lappa Decne., Terminalia chebula Retz., Melia toosendan Sieb. et Zucc., Gardenia jasminoides Ellis, Sophora flavescens Ait., Potentilla discolor Bunge, Dianthus superbus Linn., Eugenia caryophyllata Thunb., Glycyrrhiza glabra Linn., Vitis vinifera L., Cyperus rotundus L., Cinnamomum cassia Presl, Punica granatum L., Carthamus tinctorius L., Ilex purpurea Hassk., Alpinia oxyphylla Miq., Piper longum L., Neptunea arthritica cumingii, Bistorta officinalis Z. in specific weight part ratios. In the formula, Vitis vinifera L. and Myristica fragrans Houtt. are monarch drugs, Ilex purpurea Hassk., Carthamus tinctorius L., Gypsum Fibrosum, Glycyrrhiza glabra Linn., Adenophora stricta Miq., Cyperus rotundus L., Choerospatha eriostachya (Wall.) Miq., Santalum album Linn., Aquilaria sinensis (Lour.) Gilg are ministerial drugs, and the rest are adjuvant and guiding drugs. The total weight part ratio of the monarch drugs to the ministerial drugs is 1:3.0 - 3.4, and the total weight part ratio of the heat-clearing medicinal materials to the stomach-warming medicinal materials among the adjuvant and guiding drugs is 1:1.1 - 1.5. The present invention realizes the synchronous regulation of the disorder of Heretic and Badagan through scientific ratio, and takes into account the treatment of lung symptoms and gastrointestinal functions.

This invention relates to the field of traditional Chinese medicine compositions, and discloses a traditional Chinese medicine composition for relieving and treating dry eye syndrome and its preparation method. The traditional Chinese medicine composition comprises the following components in parts by weight: 20-30 parts of Rehmannia glutinosa, 10-15 parts of Adenophora stricta, 8-12 parts of Ophiopogon japonicus, 5-10 parts of modified Gentiana scabra extract, 5-10 parts of Angelica sinensis, 10-15 parts of Lycium barbarum, 5-10 parts of Paeonia suffruticosa bark, 2-7 parts of Buddleja officinalis, and 3-5 parts of Melia toosendan; the modified Gentiana scabra extract is prepared using β-cyclodextrin. The esterification reaction of maleic anhydride yields maleic acid monoester cyclodextrin, which is then subjected to a Michael addition reaction with chitosan quaternary ammonium salt to obtain modified cyclodextrin, which is then used to encapsulate gentian root extract. This invention utilizes Rehmannia glutinosa, Adenophora stricta, Ophiopogon japonicus, Angelica sinensis, Lycium barbarum, Paeonia suffruticosa, Buddleja officinalis, and Melia toosendan as traditional Chinese medicine raw materials to extract traditional Chinese medicine extracts. The modified gentian root extract is added to the traditional Chinese medicine extracts for combined use, which can effectively achieve the long-term effect of the traditional Chinese medicine composition.